Ambu A/S

AMBU-B · Nasdaq Copenhagen · Healthcare

67.35DKK +0.4%last day

Price as of 2 October 2026

The price over the past year, with dividends: −28.7%

Performance

1 month

−3.7%

1 year

−28.7%

3 years, per year

−3.9%

5 years, per year

−20.5%

Largest fall, 3 years

−81.4%

Below the peak now

−80.9%

Volatility, 1 year

38.6%

Return with dividends reinvested.

Key figures

P/E

34.7

P/B

2.9

Dividend yield

0.6%

Return on equity

+8.3%

Net margin

+8.2%

Market value

2.7 bn USD

Quality, value and trend

Where Ambu stands against every Nordic stock today. 100 is best.

Quality84

Profitability and a sound balance sheet over time. Better than 84% of Nordic stocks.

Value32

The price measured against earnings, assets and cash flow. Better than 32% of Nordic stocks.

Trend36

The price development over the past year. Better than 36% of Nordic stocks.

Combined48

Quality, value and trend together. Better than 48% of Nordic stocks.

About Ambu

Ambu A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 5,200 employees.

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis